The overall mission ofthe UNC Center for Gastrointestinal Biology and Disease (CGIBD) is to promote and enhance multidisciplinary research in digestive diseases. This mission is accomplished in part, through core laboratories that provide laboratory services, training, and technical support to center members. The Histology Core supports CGIBD's mission by providing essential histopathological services to members conducting digestive diseases research. The services provided by the Core include consultation during the planning phase of experiments, analysis of human and mouse intestine, liver, pancreas, and other GI related tissue specimens for histology and immunohistochemistry. We also provide access to four fluorescent microscopes; a Zeiss AXio Imager, a Zeiss AXio Primo Star Microscope and Olympus IX71 and IX81 inverted fluorescence microscopes. In addition, the Core provides digital slide scanning and image analysis services in partnership with the UNC Translational Pathology Laboratory (TPL; https://tpl.med.unc.edu/l A new service is to provide brightfield and fluorescent live cell imaging to users. The main goal of TPL is to take laboratory research discoveries into the realm of clinical care in a timely manner. The partnership wdth the TPL is beneficial because it allows the CGIBD Histology Core to provide cutting edge digital imaging services to Center members. The Core personnel include a faculty director, a histotechnician, and research assistants who vsdll oversee the slide digitization process. The Core Director has broad expertise in histology and cancer biomarkers and oversees the administration ofthe Core. The histotechnician has over 15 years experience in histopathology and is responsible for sample preparation and processing for histological analysis and digital imaging on a fee for service basis. She has two research assistants who help her with these duties. As can be seen from the Core Use report, the Core is heavily utilized by Center members and other researchers at UNC

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034987-33
Application #
9391670
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
33
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Palacios, Michelle; Miner, Taryn A; Frederick, Daniel R et al. (2018) Identification of Two Regulators of Virulence That Are Conserved in Klebsiella pneumoniae Classical and Hypervirulent Strains. MBio 9:
Williamson, Ian A; Arnold, Jason W; Samsa, Leigh Ann et al. (2018) A High-Throughput Organoid Microinjection Platform to Study Gastrointestinal Microbiota and Luminal Physiology. Cell Mol Gastroenterol Hepatol 6:301-319
Zhang, Cun-Jin; Wang, Chenhui; Jiang, Meiling et al. (2018) Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun 9:2745
Evon, Donna M; Golin, Carol E; Ruffin, Rachel et al. (2018) Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C. Pilot Feasibility Stud 4:92
Busch, Evan L; Don, Prabhani Kuruppumullage; Chu, Haitao et al. (2018) Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors. BMC Cancer 18:82
Herfarth, Hans; Barnes, Edward L; Valentine, John F et al. (2018) Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis. Gastroenterology 155:1098-1108.e9
Koutlas, N T; Eluri, S; Rusin, S et al. (2018) Impact of smoking, alcohol consumption, and NSAID use on risk for and phenotypes of eosinophilic esophagitis. Dis Esophagus 31:1-7
Reese, Aspen T; Cho, Eugenia H; Klitzman, Bruce et al. (2018) Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut. Elife 7:
Walker, Miriam Y; Pratap, Siddharth; Southerland, Janet H et al. (2018) Role of oral and gut microbiome in nitric oxide-mediated colon motility. Nitric Oxide 73:81-88
Smid, Marcela C; Ricks, Nitasha M; Panzer, Alexis et al. (2018) Maternal Gut Microbiome Biodiversity in Pregnancy. Am J Perinatol 35:24-30

Showing the most recent 10 out of 944 publications